UK markets closed

Lyra Therapeutics, Inc. (LYRA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
0.3830+0.0154 (+4.19%)
At close: 04:00PM EDT
0.3879 +0.00 (+1.28%)
After hours: 07:58PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
22,353
32,550
45,747
74,593
Other short-term investments
80,400
65,344
0
-
Total cash
102,753
97,894
45,747
74,593
Other current assets
2,068
2,935
2,171
1,324
Total current assets
104,821
100,829
47,918
75,917
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
37,197
8,640
9,737
7,344
Accumulated depreciation
-1,921
-4,174
-3,879
-2,878
Net property, plant and equipment
35,276
4,466
5,858
4,466
Other long-term assets
2,503
4,673
1,091
447
Total non-current assets
37,779
9,139
6,949
4,913
Total assets
142,600
109,968
54,867
80,830
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
3,131
2,616
3,125
922
Accrued liabilities
8,143
6,410
3,625
2,828
Deferred revenues
1,658
1,275
9,789
0
Other current liabilities
1,231
659
633
149
Total current liabilities
19,597
14,470
18,246
4,884
Non-current liabilities
Deferred revenues
12,136
14,077
1,926
0
Total non-current liabilities
33,583
14,744
2,305
1,454
Total liabilities
53,180
29,214
20,551
6,338
Stockholders' equity
Common stock
57
32
13
13
Retained earnings
-311,355
-248,675
-193,397
-149,884
Accumulated other comprehensive income
33
10
0
-
Total stockholders' equity
89,420
80,754
34,316
74,492
Total liabilities and stockholders' equity
142,600
109,968
54,867
80,830